Triple
T18213154
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | vincristine |
E436082
|
entity |
| Predicate | usedInRegimen |
P25490
|
FINISHED |
| Object | VCR–prednisone–L-asparaginase regimens |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: VCR–prednisone–L-asparaginase regimens | Statement: [vincristine, usedInRegimen, VCR–prednisone–L-asparaginase regimens]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: VCR–prednisone–L-asparaginase regimens Context triple: [vincristine, usedInRegimen, VCR–prednisone–L-asparaginase regimens]
-
A.
BEACOPP regimen
The BEACOPP regimen is an intensive multi-drug chemotherapy protocol used primarily for advanced-stage Hodgkin lymphoma.
-
B.
R-CHOP
R-CHOP is a standard chemotherapy regimen combining rituximab with multiple cytotoxic drugs, commonly used to treat non-Hodgkin lymphoma.
-
C.
vincristine
Vincristine is a chemotherapy medication, specifically a vinca alkaloid, widely used in combination regimens to treat various cancers including lymphomas and leukemias.
-
D.
Bicutan
Bicutan is a district in Taguig, Metro Manila, Philippines, known for its residential areas, government offices, and commercial developments.
-
E.
ABVD regimen
The ABVD regimen is a standard chemotherapy combination used as first-line treatment for classical Hodgkin lymphoma.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: VCR–prednisone–L-asparaginase regimens Target entity description: VCR–prednisone–L-asparaginase regimens are combination chemotherapy protocols commonly used in the treatment of acute lymphoblastic leukemia, particularly in pediatric patients.
-
A.
BEACOPP regimen
The BEACOPP regimen is an intensive multi-drug chemotherapy protocol used primarily for advanced-stage Hodgkin lymphoma.
-
B.
R-CHOP
R-CHOP is a standard chemotherapy regimen combining rituximab with multiple cytotoxic drugs, commonly used to treat non-Hodgkin lymphoma.
-
C.
vincristine
Vincristine is a chemotherapy medication, specifically a vinca alkaloid, widely used in combination regimens to treat various cancers including lymphomas and leukemias.
-
D.
Bicutan
Bicutan is a district in Taguig, Metro Manila, Philippines, known for its residential areas, government offices, and commercial developments.
-
E.
ABVD regimen
The ABVD regimen is a standard chemotherapy combination used as first-line treatment for classical Hodgkin lymphoma.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d8b90dba6481908e119eb9aa4ca0cb |
completed | April 10, 2026, 8:47 a.m. |
| NER | Named-entity recognition | batch_69e4e22a26308190a6720b41a9bbfc2d |
completed | April 19, 2026, 2:09 p.m. |
Created at: April 10, 2026, 10:32 a.m.